Cargando…
Methods for Detecting Circulating Cancer Stem Cells (CCSCs) as a Novel Approach for Diagnosis of Colon Cancer Relapse/Metastasis
Cancer stem cells (CSCs) are believed to be resistant to currently available therapies and maybe responsible for relapse of cancer in patients. Measuring circulating tumor cells (CTCs) in blood of patients has emerged as a non-invasive diagnostic procedure for screening patients who may be at high r...
Autores principales: | Kantara, Carla, O’Connell, Malaney, Luthra, Gurinder, Gajjar, Aakash, Sarkar, Shubhashish, Ullrich, Robert, Singh, Pomila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281282/ https://www.ncbi.nlm.nih.gov/pubmed/25347154 http://dx.doi.org/10.1038/labinvest.2014.133 |
Ejemplares similares
-
Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications
por: O’Connell, Malaney R., et al.
Publicado: (2015) -
A novel antibody against cancer-stem-cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy
por: Sarkar, Shubhashish, et al.
Publicado: (2017) -
Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients
por: Pizon, Monika, et al.
Publicado: (2022) -
Novel Regenerative Peptide TP508 Mitigates Radiation-Induced Gastrointestinal Damage By Activating Stem Cells and Preserving Crypt Integrity
por: Kantara, Carla, et al.
Publicado: (2015) -
Breast Cancer Metastasis Masquerading as Primary Colon and Gastric Cancer: A Case Report
por: Noor, Arish, et al.
Publicado: (2020)